Company Filing History:
Years Active: 2018-2020
Title: Xiaomeng Zhao: Innovator in Chemical and Pharmaceutical Technology
Introduction
Xiaomeng Zhao is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of chemical and pharmaceutical technology. With a focus on innovative solutions, Zhao has been awarded 2 patents for his groundbreaking work.
Latest Patents
Zhao's latest patents include a STAT3 and ERK signal pathway inhibitor comprising mogrosides and analogs thereof. This invention relates to a chemical and pharmaceutical technology aimed at inhibiting the phosphorylation of transcription factors STAT3 and ERK. The inhibitor primarily consists of mogrosides and/or their analogs, which have shown effectiveness in treating tumors by inhibiting cancer cell proliferation and promoting apoptosis. Another notable patent is a unified data model for integration between relational and non-relational databases. This invention addresses the challenges posed by schema-less databases, improving data modeling and management by inferring a schema that enhances integration with relational database management systems (RDBMS).
Career Highlights
Throughout his career, Xiaomeng Zhao has worked with notable organizations, including Beijing University of Agriculture and Ca, Inc. His work has significantly impacted the fields of data management and cancer treatment, showcasing his versatility as an inventor.
Collaborations
Zhao has collaborated with several professionals in his field, including Can Liu and Lanqing Ma. These collaborations have further enriched his research and development efforts.
Conclusion
Xiaomeng Zhao is a distinguished inventor whose contributions to chemical and pharmaceutical technology have the potential to transform treatment methodologies and data integration processes. His innovative patents reflect a commitment to advancing science and technology.